Member Exclusive NEWS ROUND-UP

Cell therapy weekly: Vital Therapies abandons liver cell therapy, loses 80% share price

This week in cell therapy: Cell and Gene Therapy Catapult is granted MHRA manufacturing licenses and baby teeth stem cells shown to regrow damaged dental tissue.

Go to the profile of RegMedNet
Sep 13, 2018
0
0

Please sign in or register for FREE

No comments yet.